Results for the substance olipudas alfa

Olipudase alfa is a medication used for the treatment of acid sphingomyelinase deficiency, also known as Niemann-Pick disease type A or B. It is an enzyme replacement therapy that helps break down accumulated sphingomyelin in cells, thereby reducing disease symptoms.

The medication is administered intravenously, as directed by your doctor, usually at regular intervals. It is important to monitor side effects and undergo periodic tests to assess the effectiveness of the treatment.

Side effects may include injection site reactions, fever, headache, fatigue, or, in rare cases, severe allergic reactions.

Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of olipudase alfa.